Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.95 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.95 |
| ▸ | F3 | P13726 | 3/20 | 0.95 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.95 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.95 |
| ▸ | LMNA | P02545 | 2/20 | 0.95 |
| ▸ | RECQL | P46063 | 2/20 | 0.95 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.95 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.95 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.95 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.95 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.70 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.70 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.70 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.70 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.70 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.70 |
| ▸ | TNKS | O95271 | 1/20 | 0.70 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL546073 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL7512289 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL509571 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL1646390 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL5111 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL14832106 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL2438441 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL18039478 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL187662 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 | |
| SCHEMBL21879664 | 1.00 | MAPT (0.95) | MAPTCYP2C9F3CYP1A2PLIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 295 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250250272-A1 | Diamine Compound, Polyimide Acid, Polyimide, and Preparation Method Therefor and Use Thereof | BYD COMPANY LIMITED (CN) | 2025-08-07 | — | — | US | claimed |
| WO-2020119549-A1 | METHOD FOR DIRECTLY CONSTRUCTING TETRA-SUBSTITUTED ALLENIC ACID COMPOUND HAVING HIGH OPTICAL ACTIVITY | 复旦大学 | 2020-06-18 | — | — | WO | claimed |
| US-8450495-B2 | 11C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent | GE HEALTHCARE LIMITED (GB) | 2013-05-28 | — | — | US | claimed |
| US-20130005984-A1 | 11C-LABELED BENZOPHENONE/BENZOXAZOLE ANALOGUES AS AN INFLAMMATION IMAGING AGENT | GE HEALTHCARE LIMITED (GB) | 2013-01-03 | — | — | US | claimed |
| US-8309770-B2 | 11C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent | GE HEALTHCARE LIMITED (GB) | 2012-11-13 | — | — | US | claimed |
| WO-2007135541-A1 | 11C-LABELED BENZOPHENONE/BENZOXAZOLE ANALOGUES AS AN INFLAMMATION IMAGING AGENT | GE HEALTHCARE LIMITED (GB) | 2007-11-29 | — | — | WO | claimed |
| WO-2005056536-A1 | ANTIDIABETIC AGENTS WHICH EXHIBIT ACTIVITY AGAINST PPAR | RANBAXY LABORATORIES LIMITED (IN) | 2005-06-23 | — | — | WO | claimed |
| EP-4665129-A1 | ORGANIC LIGHT-EMITTING DIODE WITH LOW VOLTAGE, HIGH EFFICIENCY, AND LONG LIFESPAN | SFC Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250380564-A1 | ORGANIC LIGHT-EMITTING DIODE WITH LOW VOLTAGE, HIGH EFFICIENCY, AND LONG LIFESPAN | SFC CO LTD (KR) | 2025-12-11 | — | — | US | disclosed |
| US-20250326722-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) | 2025-10-23 | — | — | US | disclosed |
| US-20250250272-A1 | Diamine Compound, Polyimide Acid, Polyimide, and Preparation Method Therefor and Use Thereof | BYD COMPANY LIMITED (CN) | 2025-08-07 | — | — | US | disclosed |
| US-11997870-B2 | Organic electroluminescent element and method for producing same | HODOGAYA CHEMICAL CO., LTD. (JP) | 2024-05-28 | — | — | US | disclosed |
| EP-4207947-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME | HODOGAYA CHEMICAL CO LTD (JP) | 2024-03-13 | — | — | EP | disclosed |
| EP-0937077-A1 | PYRIDONE-FUSED AZABICYCLIC- OR CYTISINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN ADDICTION THERAPY | PFIZER INC. (US) | 1999-08-25 | — | — | EP | disclosed |
| EP-0905118-A1 | Unsaturated 6-tert-butyl-1,1-dimethylindane derivates substituted in the 4-position and their use in human and veterinary medicine as well as in cosmetics | Galderma Research & Development, S.N.C. (FR) | 1999-03-31 | — | — | EP | disclosed |
| EP-0854139-A2 | Vitamin D3 derivative and production process thereof | TEIJIN LIMITED (JP) | 1998-07-22 | — | — | EP | disclosed |
| WO-1998018798-A1 | PYRIDONE-FUSED AZABICYCLIC- OR CYTISINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN ADDICTION THERAPY | PFIZER INC. (US) | 1998-05-07 | — | — | WO | disclosed |
| US-5719297-A | Vitamin D3 derivatives and production process thereof | TEIJIN LIMITED (JP) | 1998-02-17 | — | — | US | disclosed |
| EP-0712843-A1 | VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | TEIJIN LIMITED (JP) | 1996-05-22 | — | — | EP | disclosed |
| EP-0296550-A2 | Phosphonium salts and processes for production of and uses for the same | KURARAY CO., LTD. (JP) | 1988-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250272-A1 | Diamine Compound, Polyimide Acid, Polyimide, and Preparation Method Therefor and Use Thereof | WEE1, WEE2, DDC | MAPT 2698/4885CYP2C9 2229/4885F3 1029/4885 |
| US-20130005984-A1 | 11C-LABELED BENZOPHENONE/BENZOXAZOLE ANALOGUES AS AN INFLAMMATION IMAGING AGENT | GMPS, NLRP3, IL17A | MAPT 2449/4885CYP2C9 146/4885F3 1687/4885 |
| US-20250326722-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | WEE1, WEE2, NOS1 | MAPT 2273/4885CYP2C9 231/4885F3 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.